An miRNA Fingerprint Using Neural-Enriched Extracellular Vesicles from Blood Plasma: Towards a Biomarker for Amyotrophic Lateral Sclerosis/Motor Neuron Disease

An miRNA Fingerprint Using Neural-Enriched Extracellular Vesicles from Blood Plasma: Towards a Biomarker for Amyotrophic Lateral Sclerosis/Motor Neuron Disease

Posted by Adam Awdish on

Single Donor Human Plasma (Blood Derived) from Innovative Research was used in the following study:

 

An miRNA Fingerprint Using Neural-Enriched Extracellular Vesicles from Blood Plasma: Towards a Biomarker for Amyotrophic Lateral Sclerosis/Motor Neuron Disease

Sandra Anne Banack, Rachael Anne Dunlop and Paul Alan Cox

The Royal Society Publishing
May 22, 2020

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) continue to provide challenges for diagnosis since validated diagnostic biomarkers are currently unavailable. Rapid diagnosis and intervention in the disease process could be beneficial in slowing neurodegenerative disease progression as well as facilitating the testing of new therapies. For patients with ALS/MND, the average time from diagnosis to death is typically between 2–5 years, and it is not unusual for patients to wait a year before receiving a diagnosis.

Since disease progression correlates with motor neuron loss, early intervention could be critical for the development of new effective drug therapies. Currently, there are no known reliable biomarkers for ALS/ MND diagnosis or analysis of disease progression. If identified, biomarkers could improve patient outcomes by enabling early intervention and assist in the determination of treatment efficacy.

In this study, researchers hypothesized that neural-enriched extracellular vesicles could provide microRNA (miRNA) fingerprints with unequivocal signatures of neurodegeneration. Using blood plasma from ALS/MND patients and controls, scientists extracted neural-enriched extracellular vesicle fractions and conducted next-generation sequencing and qPCR of miRNA components of the transcriptome.

The researchers were able to identify eight miRNA sequences which significantly distinguish ALS/MND patients from controls in a replicated experiment using a second cohort of patients and controls. miRNA sequences from patient blood samples using neural-enriched extracellular vesicles may yield unique insights into mechanisms of neurodegeneration and assist in early diagnosis of ALS/MND.

 

Related products available from Innovative Research also include:

Pooled Human Plasma (Blood Derived)

Pooled Human Complement Serum

Single Donor Human Whole Blood

  • Tags: Human Plasma, Single Donor Human Plasma Whole Blood Derived

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Exploring the Versatility of Innovative Research's Native Proteins in Scientific Research
    Scientists and researchers are constantly seeking high-quality, reliable tools to advan...
    Read the Article
    2024 Top Research Biologicals
    Innovative Research is excited to share our top research products so far in the year 20...
    Read the Article
    Unlock Your Research Potential with Our Premier E. Coli Competent Cells
    Dive into the world of unparalleled genetic research with our diverse lineup of E. coli...
    Read the Article

    ← Older Post Newer Post →

    ×